8,955 reports of this reaction
3.9% of all TERIPARATIDE reports
#1 most reported adverse reaction
NAUSEA is the #1 most commonly reported adverse reaction for TERIPARATIDE, manufactured by Eli Lilly and Company. There are 8,955 FDA adverse event reports linking TERIPARATIDE to NAUSEA. This represents approximately 3.9% of all 227,333 adverse event reports for this drug.
TERIPARATIDE has an overall safety score of 78 out of 100. Patients taking TERIPARATIDE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among TERIPARATIDE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for TERIPARATIDE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 8,955 FDA reports for TERIPARATIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.9% of all adverse event reports for TERIPARATIDE, making it one of the most commonly reported side effect.
If you experience nausea while taking TERIPARATIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.